Roche breast cancer pill fails to help older women

[News]

Swiss drugmaker Roche Holding AG's oral chemotherapy drug Xeloda,or capecitabine, proved inferior to standard chemotherapy intreating older women with early stage breast cancer, a studyreleased on Saturday at a major meeting of oncology specialistsfound.

More... (http://www.healthcentral.com/breast-cancer/news-253396-66.html)